773873-72-6 Usage
Uses
Used in Pharmaceutical Industry:
METHYL 3,4,5-TRIFLUOROBENZENECARBOXYLATE is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and improving the efficacy of existing ones.
Used in Agrochemical Industry:
METHYL 3,4,5-TRIFLUOROBENZENECARBOXYLATE is used as a chemical intermediate in the production of agrochemicals, such as pesticides and herbicides, to enhance crop protection and increase agricultural productivity.
It is important to handle and store METHYL 3,4,5-TRIFLUOROBENZENECARBOXYLATE with care due to its highly flammable nature and potential health hazards. Exposure to high temperatures may cause decomposition, and contact with the skin, eyes, or respiratory system can result in irritation. Proper safety measures should be taken to minimize risks during its use in both pharmaceutical and agrochemical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 773873-72-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,3,8,7 and 3 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 773873-72:
(8*7)+(7*7)+(6*3)+(5*8)+(4*7)+(3*3)+(2*7)+(1*2)=216
216 % 10 = 6
So 773873-72-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H5F3O2/c1-13-8(12)4-2-5(9)7(11)6(10)3-4/h2-3H,1H3
773873-72-6Relevant academic research and scientific papers
MODULATORS OF ESTROGEN RECEPTOR PROTEOLYSIS AND ASSOCIATED METHODS OF USE
-
Paragraph 00463, (2018/08/20)
The present disclosure relates to bifunctional compounds, which find utility as modulators of estrogen receptor (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a cereblon, Von Hippel-Lindau ligase-binding moiety, Inhibitors of Apotosis Proteins, or mouse double-minute homolog 2 ligand, which binds to the respective E3 ubiquitin ligase, and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.
CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVE
-
Paragraph 0516; 0518, (2018/09/12)
PROBLEM TO BE SOLVED: To provide a compound having excellent retinoic acid receptor related orphan receptor γt inhibition effect and useful as a therapeutic agent for psoriasis or the like. SOLUTION: There is provided a compound represented by the general
